Mariana Socal on the Global Supply Chain for Generic Drugs

Alan Weil interviews Mariana Socal on the global supply chain for generic drugs. They discuss the heavy reliance and lack of competition in the market, the role of active pharmaceutical ingredients in the supply, the vulnerability and potential disruptions in drug production, the limited number of producers in the global supply chain, and the competition and vulnerability in the US market. They highlight the need for better monitoring and inspection for international sources to ensure quality and functionality in the generics market.